EGFR exon 20 insertions mutation in lung adenocarcinoma and its response by high-dose of Furmonertinib: a real-world study by Sen Yang, Yang Liu, Jiuzhou Zhao, Zhen He, Haiyang Chen, Shuxiang Ma, Yingxi Wu, Yufeng Wu, Lili Wang, Cuicui Zhang, Qiming Wang

Subjects: “…EGFR…”
Get full text

High-dose furmonertinib plus bevacizumab in EGFR-mutant non-small cell lung cancer with brain metastases after resistance to third-generation EGFR-TKIs: A retrospective study by Yin Pan, Meichen Li, Mingjie Yu, Jing Chen, Hui Yu, Kaijing Liu, Likun Chen

Subjects: Get full text

Efficacy of icotinib in advanced lung squamous cell carcinoma by Shuai Liang, Yan Xu, Fenlai Tan, Lieming Ding, Yongbin Ma, Mengzhao Wang

Subjects: Get full text

A CMTM6 Nanobody Overcomes EGFR‐TKI Resistance in Non‐Small Cell Lung Cancer by Lu Xia, Jichuan Wang, Hui Xue, Haimeng Li, Qinghua Li, Sen Qin, Chunyu Yu, Yanhua Liu, Yu Gao, Lingyun Li, Sudun Guan, Enrun Zheng, Feiya Suo, Lin He, Yongsheng Wang, Wenling Han, Yongfeng Shang, Yong Geng, Luyang Sun

Subjects: Get full text

Evaluation of Race-Neutral Glomerular Filtration Rate Estimating Equations in an Indian Population by Ashok Kumar Yadav, Jaskiran Kaur, Prabhjot Kaur, Kajal Kamboj, Yoshinari Yasuda, Masaru Horio, Arnab Pal, Nusrat Shafiq, Nancy Sahni, Harbir Singh Kohli, Seiichi Matsuo, Vivek Kumar, Vivekanand Jha

Subjects: Get full text

Rational computational Design of new-Generation EGFR tyrosine kinase (EGFR-TK) inhibitors by Chandraprakash Gond, Nikhil Kumar, Akanksha Mishra, Shivani Daksh, Anupama Datta, Anjani Kumar Tiwari

Subjects: Get full text

Discovery of BBT-176 as a fourth-generation EGFR tyrosine kinase inhibitor by Krishna Babu Duggirala, Hyeonjeong Choe, Byeong Uk Jeon, Chaewon Park, Jiyeun Yoon, Hwan Kim, Myoung Eun Jung, Gildon Choi, Chong Hak Chae, Byoung Chul Cho, Kwangho Lee

Subjects: “…EGFR-TKIs…”
Get full text

Assessment of the effectiveness of surgical resections following tyrosine kinase inhibitor therapy in patients with EGFR-mutated stage III–IV lung adenocarcinoma by E. V. Levchenko, F. V. Moiseenko, S. V. Orlov, E. N. Imyanitov, A. E. Mikhnin, M. L. Gelfond, E. N. Slugin, S. M. Ergnyan, N. E. Levchenko, A. S. Zhabina, A. M. Ulitin, O. Yu. Mamontov, O. O. Lopushanskaya, E. V. Artemeva, A. I. Murtazin, V. I. Shabinskaya

Subjects: Get full text

Current Status and Future Prospects of Treatment for EGFR-Positive Non-Small Cell Lung Cancer After Resistance to EGFR-TKI by Yiming ZENG, Wenfeng FANG, Li ZHANG

Subjects: “…egfr-mutant nsclc…”
Get full text

Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer by Chen CY, Ko HW, Hu PW, Chang CY, Chen CY, Chang SC, Chiu YC, Wei YF

Subjects: Get full text

Advancements in Targeted Therapy for Oral Cancer: A Mini Review by Sakshi G. Ingole, Ashwini A. Aher, Sunil N. Thitame

Subjects: Get full text

Association Between Malondialdehyde and Glomerular Filtration Rate Among Patients Attending National Orthopaedic Hospital Dala- Kano, Nigeria by Adamu, S.M. *, Wudil, A.M., Ibekwe, E.C., Koki, Y.A., Adamu, S., Abdullahi, S.A. and Abbas, A.M.

Subjects: “…creatinine, egfr, malondialdehyde and kidney…”
Get full text

Safety and efficacy of the combination of selpercatinib with osimertinib in NSCLC: a case report and review of the literature by Blerina Resuli, Blerina Resuli, Heidi Galarza, Heidi Galarza, Diego Kauffmann-Guerrero, Diego Kauffmann-Guerrero, Julian Oversohl, Julian Oversohl, Jürgen Behr, Jürgen Behr, Amanda Tufman, Amanda Tufman

Subjects: Get full text

First‐Line Osimertinib for EGFR‐Mutated Squamous Cell Lung Carcinoma: A Case Report by Yugo Matsumura, Seiya Ichihara, Kaori Nii, Kazumasa Nanjo, Naoki Kadota, Yoshio Okano, Hisanori Machida, Nobuo Hatakeyama, Hiroyuki Hino, Keishi Naruse, Tsutomu Shinohara, Shoji Sakiyama, Eiji Tacheuchi

Subjects: Get full text

The correlation of HLA-A in Thai EGFR-mutated advanced non-small cell lung cancer, outcome, and tumor microenvironment by Nicha Zungsontiporn, Korakot Srianuwattipong, Sakun Santisukwongchote, Piyada Sitthideatphaiboon, Poonchavist Chantranuwat, Chatchawit Aporntewan, Chanida Vinayanuwattikun

Subjects: Get full text

The effectiveness of three months EGFR-CTH therapy in palliative colorectal cancer by Maciej Pawel Jankowski, Krystyna Bratos, Tomasz Urbanowicz

Subjects: “…EGFR-CTH…”
Get full text

Association of MPO levels with cardiometabolic disease stratified by atherosclerotic cardiovascular risk and intensity of therapy in a workforce population by Olga A. Iakoubova, Farnoosh Haji-Sheikhi, Judy Z. Louie, Charles M. Rowland, Andre R. Arellano, Lance A. Bare, Charles E. Birse, Marc S. Penn

Subjects: Get full text

Suppression of Epidermal Growth Factor Receptor by Erlotinib Attenuates Carvacrol-induced Skin Inflammation by Yujing Wang, Wenjie Huang, Haidong Jia, Qinglian Tang, Qingfei Yin, Yuanyuan Chen, Wumei Wang, Zhengyu Cao

Subjects: Get full text

Design, synthesis and biological evaluation of a series of dianilinopyrimidines as EGFR inhibitors by Longjia Yan, Qin Wang, Li Liu, Yi Le

Subjects: Get full text

An in-depth exploration of four heterogeneity structure-based EGFR mutation subgroups in Chinese non-small cell lung cancer by Yongfeng Yu, Fei Yao, Jin Wang, Zhan Huang, Tao Hu, Changbin Zhu, Shun Lu

Subjects: Get full text